Syndecan-4 proteoliposomes enhance fibroblast growth factor-2 (FGF-2)-induced proliferation, migration, and neovascularization of ischemic muscle - Wikidata - wikimedia - TriplyDB

Syndecan-4 proteoliposomes enhance fibroblast growth factor-2 (FGF-2)-induced proliferation, migration, and neovascularization of ischemic muscle

Syndecan-4 proteoliposomes enhance fibroblast growth factor-2 (FGF-2)-induced proliferation, migration, and neovascularization of ischemic muscle

http://www.wikidata.org/entity/Q24633567

about

Biomaterials and Nanotherapeutics for Enhancing Skin Wound Healing Nanoscale strategies: treatment for peripheral vascular disease and critical limb ischemia.Bone marrow mesenchymal stem cells overexpressing human basic fibroblast growth factor increase vasculogenesis in ischemic rats Syndecan-1 regulates vascular smooth muscle cell phenotype.The expression profiles of fibroblast growth factor 9 and its receptors in developing mice testes.VE-statin/Egfl7 expression in malignant glioma and its relevant molecular network Hyperspectral imaging using the single-pixel Fourier transform technique.Overcoming disease-induced growth factor resistance in therapeutic angiogenesis using recombinant co-receptors delivered by a liposomal system.Killing two birds with one stone: dual blockade of integrin and FGF signaling through targeting syndecan-4 in postoperative capsular opacification.Minireview: Syndecans and their crucial roles during tissue regeneration.Syndecan-4 is associated with beta-cells in the pancreas and the MIN6 beta-cell line.Syndesome Therapeutics for Enhancing Diabetic Wound Healing Syndecan-4 Enhances Therapeutic Angiogenesis after Hind Limb Ischemia in Mice with Type 2 Diabetes.The IL-1RI Co-Receptor TILRR (FREM1 Isoform 2) Controls Aberrant Inflammatory Responses and Development of Vascular Disease.Glypican-1 nanoliposomes for potentiating growth factor activity in therapeutic angiogenesis Syndecan 4 regulation of PDK1-dependent Akt activation.* Glioblastoma Exosomes for Therapeutic Angiogenesis in Peripheral Ischemia.Syndecan-4: a novel regulator of collagen synthesis and deposition in the pressure-overloaded myocardium.Biomimicking Platelet-Monocyte Interactions as a Novel Targeting Strategy for Heart Healing.Resveratrol Improves Tube Formation in AGE-Induced Late Endothelial Progenitor Cells by Suppressing Syndecan-4 Shedding.

P2860

Q28077978-5E927C7F-C07C-4016-86D8-93FE3E257683 Q33864915-85A6F343-3C66-4773-A60E-2B06CCE8C7E6 Q34272428-B693ED54-616E-4C91-9412-DD2C03C1B663 Q35108169-AC6E1932-F8F8-4558-9372-9B528A5CEDB1 Q37168110-E0DE9232-5B1E-435D-BFB8-04F973B66A75 Q37676750-3926F05B-864F-4451-B08D-C3CCA4F51848 Q37719509-DD5DAA7F-A5C7-4A5E-893A-C9F50C4FBC52 Q38311837-8CC2B733-DFF1-4B46-9724-A338EE3CCF22 Q38658250-15AEEC3F-F789-4905-A7C8-A48718EFD94D Q38887755-164E3B38-7F81-46A8-A631-5E8962FDD351 Q39300907-15575E66-D6F9-44D3-9493-D278FB0EA86E Q41421987-0ECC91CE-55DC-4C70-A64D-FE8CA685CFCE Q41423118-83465166-6759-43BD-ADCC-9A93F0540D13 Q41599612-FAF7685C-8C7B-4797-ACE5-B83F4BF48CB0 Q41728328-E62F451B-B8D9-4F2D-AA10-B9D517504A8C Q42360066-74F4D692-3C38-4039-A9AB-58BE38A466FC Q47933631-98CDE802-2843-489A-BD6F-8A7D36E67475 Q48088929-1B5A9999-7FF8-411A-ADA8-BA3A06DE6625 Q48957301-75296D36-1344-4A45-8E08-85F449E6610C Q55005437-EB51DE7D-6E42-4469-9D7E-44DC2D035ED2

P2860

Syndecan-4 proteoliposomes enhance fibroblast growth factor-2 (FGF-2)-induced proliferation, migration, and neovascularization of ischemic muscle

http://www.wikidata.org/entity/Q24633567

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Syndecan-4 proteoliposomes enh ...... ularization of ischemic muscle

@ast

Syndecan-4 proteoliposomes enh ...... ularization of ischemic muscle

@en

Syndecan-4 proteoliposomes enh ...... ularization of ischemic muscle

@nl

type

label

Syndecan-4 proteoliposomes enh ...... ularization of ischemic muscle

@ast

Syndecan-4 proteoliposomes enh ...... ularization of ischemic muscle

@en

Syndecan-4 proteoliposomes enh ...... ularization of ischemic muscle

@nl

prefLabel

Syndecan-4 proteoliposomes enh ...... ularization of ischemic muscle

@ast

Syndecan-4 proteoliposomes enh ...... ularization of ischemic muscle

@en

Syndecan-4 proteoliposomes enh ...... ularization of ischemic muscle

@nl

P1433

Q24633567-ED7FF750-4839-4E3A-937E-E9F7226629D5

P1476

Q24633567-2D70B944-3D8D-4F40-A07F-13E9E8401AF9

P2093

Q24633567-325EAEB4-07F8-4D09-8F23-FFF06EAC6FB8

Q24633567-6B6EE2DC-07CD-4805-A571-7E69CEDFD1B6

Q24633567-98FECA87-56C7-4A66-9847-EDDE932B19D4

Q24633567-B74D9C27-65C2-471C-97D1-EE8FA44D48B7

P2860

Q24633567-031C98CE-362A-4C09-A052-45D262B6FE34

Q24633567-07D30785-561F-4206-9480-1AE2280F98A3

Q24633567-0DD48300-A5EA-43FA-8F50-491A8AD60D11

Q24633567-1658E833-0ED7-4888-AFB4-AF655D31504A

Q24633567-19EAA0BF-2EBF-488E-81E3-D6FEADDD68E4

Q24633567-1B01B14C-BB2F-41A1-AE1F-C5D8A0C2A381

Q24633567-2163AD32-93EB-488A-A942-C547073BEE0B

Q24633567-38455D1C-F18A-4272-B393-47D473178825

Q24633567-3CF483FB-EF24-4670-B0F5-6C4FAD2E084C

Q24633567-491C0DC7-A3D7-4EAE-A33E-266D3AE83074

P304

Q24633567-C732974F-581B-4AB0-AC6A-7543771229D9

P31

Q24633567-D9318E1A-A2C9-42DE-BD36-3963C03F2A88

P3181

Q24633567-FCFF1DD1-52F7-4C7C-9968-B75CB63DD5B7

P356

Q24633567-C687AB26-1E35-45F5-B1B9-61F86A28A32B

P407

Q24633567-4AA498B3-3DCF-4B2F-9637-63EA9636C6F7

P433

Q24633567-2C80C59A-3305-43AE-8288-4C8DFBBAD5AE

P478

Q24633567-26A9FC25-A89B-474A-9244-320FF45881EA

P50

Q24633567-6551B420-2E88-41FC-BC1C-3B8AF561AF16

P577

Q24633567-1A9D02D9-12F1-4150-9F12-5DDA4206450C

P5875

Q24633567-531AA323-FB93-4E47-A230-C0CBA3A2488D

P698

Q24633567-4B902FAC-0BDE-4274-B920-04117B10E24C

P921

Q24633567-91B4B50F-1A7A-46D0-B9FA-7536D74C8616

P932

Q24633567-2AEECA99-CD7B-4EC7-95DE-F07B3A9A5B26

P3181

P356

PNAS.1117885109

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Syndecan-4 proteoliposomes enh ...... ularization of ischemic muscle

@en

P2093

Aaron B Baker

http://www.w3.org/2001/XMLSchema#string

Elazer R Edelman

http://www.w3.org/2001/XMLSchema#string

Hassan Albadawi

http://www.w3.org/2001/XMLSchema#string

Michael T Watkins

http://www.w3.org/2001/XMLSchema#string

P2860

A novel proteoliposomal vaccine induces antitumor immunity against follicular lymphoma

Fatty acids modulate the composition of extracellular matrix in cultured human arterial smooth muscle cells by altering the expression of genes for proteoglycan core proteins

Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.

Organization and regulation of mitogen-activated protein kinase signaling pathways.

MAP kinase-mediated signalling to nucleosomes and immediate-early gene induction.

Heparin and angiogenic therapy.

Fibroblast growth factor-2.

Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.

Reduced syndecan-4 expression in arterial smooth muscle cells with enhanced proliferation.

P304

1679-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2733178

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.1117885109

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221808150

http://www.w3.org/2001/XMLSchema#string

P698

22307630

http://www.w3.org/2001/XMLSchema#string

P921

neovascularization

P932

3277125

http://www.w3.org/2001/XMLSchema#string